<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0EA52C0F-B2DE-4564-85D2-704924F54A9A"><gtr:id>0EA52C0F-B2DE-4564-85D2-704924F54A9A</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>Barbara</gtr:otherNames><gtr:surname>Lawrence</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FE007481%2F1"><gtr:id>9D07BDBF-F648-481A-88BF-96EEF0A014D3</gtr:id><gtr:title>The role of galanin-like peptide in energy balance and the involvement of inflammatory mediators: an in vivo physiological investigation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E007481/1</gtr:grantReference><gtr:abstractText>Severe weight gain (obesity) or loss (cachexia, anorexia) present massive world-wide medical and social problems. Understanding the events that control body weight will help to develop treatments for these conditions. Changes in body weight result from alterations in appetite and/or the rate of the body's metabolism. These processes are controlled by the brain through complex interactions between hormonal and nervous systems. However, it is now believed that the immune system may also play a role in the regulation of body weight through actions of inflammatory molecules such as cytokines. Leptin, a cytokine-like hormone is produced by fat cells and regulates body weight by acting in the brain. Recently it has been shown that the effects of leptin on appetite and body weight in rodents are due to changes in the cytokine interleukin-1 (IL-1). However, the way in which leptin regulates the production of IL-1 and the key messengers involved are largely unknown. Galanin-like peptide (GALP) is a small molecule that was identified recently in the brain. Injection of GALP into the brain of rodents causes a reduction in appetite and body weight, and leptin increases the production of GALP very much like IL-1. I have preliminary results to show that GALP may affect the release of IL-1 in rodents. This proposal will test whether GALP affects appetite and body weight through the production of IL-1. Part of my studies will use mice that do not have IL-1 to see if they can respond to GALP. I will also investigate where in the brain GALP is acting, and how it stimulates the release of IL-1. This work will, therefore, establish if GALP affects body weight by producing inflammatory molecules, and may also identify new ways of treating disorders of body weight regulation.</gtr:abstractText><gtr:technicalSummary>Maintenance of energy homeostasis is fundamental to life. This process is regulated by the brain and therefore understanding the mechanisms involved in the regulation of appetite and body weight is a key aim in neuroscience. Recent evidence now implicates inflammatory mediators (e.g. cytokines) in the physiological regulation of energy balance as well as disorders of energy homeostasis, such as cachexia and anorexia, and obesity. Galanin-like peptide (GALP) is a neuropeptide that has dichotomous effects on appetite and body weight, producing orexigenic effects in the short-term, but anorexigenic effects over the longer-term. The downstream mediators and mechanisms involved in these actions of GALP are currently unknown but may be due to interaction with a novel GALP-specific receptor. My preliminary data show that central administration of GALP induces expression of the pro-inflammatory cytokine interleukin-1 (IL-1) in the brain, and IL-1 may be responsible for GALP-induced anorexia. This project will use a combination of in vivo and brain cell culture studies to establish the site and mode of action of GALP in the brain and establish if IL-1 mediates its effects.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-13</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-05-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>537950</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>At present these findings have not translated to any clinical output as far as I am aware, but they will have changed the way appetite regulation is viewed</gtr:description><gtr:id>53ABD82A-5D96-4E95-95F3-728914E64E26</gtr:id><gtr:impactTypes/><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have discovered that a peptide that is located in the brain (galanin-like peptide) reduces food intake and body weight and it does this via the activation of a mediator that is normally involved in the immune response to infection (interleukin-1)</gtr:description><gtr:exploitationPathways>That cells and proteins that are normally thought to be involved in the response to infection, might also be key in mediating how we control our appetite and hence body weight.</gtr:exploitationPathways><gtr:id>660A8AB1-AED7-4D36-8040-AF91244CABE6</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B02CE0F-80C4-4D4A-934C-8E9EA83A8B81"><gtr:id>5B02CE0F-80C4-4D4A-934C-8E9EA83A8B81</gtr:id><gtr:title>Interleukin-1 mediates the anorexic and febrile actions of galanin-like Peptide.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f273e4abf76802907fa803ab4636e69"><gtr:id>7f273e4abf76802907fa803ab4636e69</gtr:id><gtr:otherNames>Man PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/026E8D3F-51CA-48E9-99BC-331DD649D5F1"><gtr:id>026E8D3F-51CA-48E9-99BC-331DD649D5F1</gtr:id><gtr:title>Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/136642c98a771a25e2fd16557f889fd6"><gtr:id>136642c98a771a25e2fd16557f889fd6</gtr:id><gtr:otherNames>Lawrence C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-3022</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AC35D79E-0C1A-4318-8786-142A3D947640"><gtr:id>AC35D79E-0C1A-4318-8786-142A3D947640</gtr:id><gtr:title>Galanin-like peptide modulates energy balance by affecting inflammatory mediators?</gtr:title><gtr:parentPublicationTitle>Physiology &amp; behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/821b6bdd6a9367b5020b706136c5fd86"><gtr:id>821b6bdd6a9367b5020b706136c5fd86</gtr:id><gtr:otherNames>Lawrence CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0031-9384</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DEE95A11-C36C-4AFA-945E-43E0E54E064C"><gtr:id>DEE95A11-C36C-4AFA-945E-43E0E54E064C</gtr:id><gtr:title>Galanin</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/136642c98a771a25e2fd16557f889fd6"><gtr:id>136642c98a771a25e2fd16557f889fd6</gtr:id><gtr:otherNames>Lawrence C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:isbn>978-3-0346-0227-3</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41EB89FF-8347-43CB-9052-D5F01FBA911D"><gtr:id>41EB89FF-8347-43CB-9052-D5F01FBA911D</gtr:id><gtr:title>Galanin-like peptide: a role in the homeostatic regulation of energy balance?</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f273e4abf76802907fa803ab4636e69"><gtr:id>7f273e4abf76802907fa803ab4636e69</gtr:id><gtr:otherNames>Man PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68F16DD9-6FEF-4526-B9A2-1B8F7B5F57FA"><gtr:id>68F16DD9-6FEF-4526-B9A2-1B8F7B5F57FA</gtr:id><gtr:title>The effects of galanin-like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor.</gtr:title><gtr:parentPublicationTitle>Journal of neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f273e4abf76802907fa803ab4636e69"><gtr:id>7f273e4abf76802907fa803ab4636e69</gtr:id><gtr:otherNames>Man PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-8194</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E007481/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>